for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Citius Pharmaceuticals says Received Written Notice From Nasdaq That Co Had Regained Compliance With Rule 5550(A)(2)

July 10 (Reuters) - Citius Pharmaceuticals Inc:

* CITIUS PHARMACEUTICALS - RECEIVED WRITTEN NOTICE FROM NASDAQ THAT CO HAD REGAINED COMPLIANCE WITH RULE 5550(A)(2) Source text - bit.ly/3ef4JrB Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up